Revolution Medicines, Inc. Common Stock

RVMDNASDAQ • USD
160.91 USD
↘ 1.78 (1.09%)🟢PRE MARKET (AS OF 05:05 AM EST)
🟢Market: OPEN

RVMD is currently priced at $160.91. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, RVMD is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Nov 18, 2026.

Open?$160.65
High?$160.91
Low?$158.86
Prev. Close?$162.69
Volume?90
Avg. Volume?2.5M
VWAP?$159.16
Rel. Volume?0.00x
Bid / Ask
Bid?$152.65 × 100
Ask?$168.93 × 100
Spread?$16.28
Midpoint?$160.79
Valuation & Ratios
Market Cap?34.6B
Shares Out?216.3M
Float?202.1M
Float %?94.3%
P/E Ratio?N/A
P/B Ratio?14.39
EPS?-$8.65
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Employees
883
Market Cap
35.2B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2020-02-13
Address
700 SAGINAW DR
REDWOOD CITY, CA 94063
Phone: 650-481-6801
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
63
Piotroski F-Score?0/9Weak
Altman Z-Score?9.21Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?6.47%Elevated
Short Interest?13.1M
Days to Cover?7.8
Free Float202.1M
Avg Daily Volume1.7M
Settlement Date2026-10-30
Financial Health
Current Ratio?8.36Strong
Quick Ratio?8.34Strong
Cash Ratio?1.29Strong
Debt/Equity?0.20Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A▾
P/B?
Peers
100
S&P
13
14.39HIGH▾
P/S?
Peers
100
S&P
3
174.97HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-20.6CHEAP▾
EV/Sales?
Peers
100
S&P
3
174.33HIGH▾
Returns & Efficiency
ROE?
S&P
3
-77.9%WEAK▾
ROA?
S&P
3
-43.5%WEAK▾
Cash Flow & Enterprise
FCF?$-1440817000
Enterprise Value?$34.4B
Fundamentals ratios updated end of day